The following are today's upgrades for Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.
QUIDEL CORPORATION (QDEL) is a mid-cap value stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Benjamin Graham changed from 71% to 86% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Quidel Corporation is primarily engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The Company's diagnostic testing solutions are separated into four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions. Its diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, QVue, Sofia, Triage, Solana, Virena, MicroVue, Lyra, FreshCells, D3, FastPoint, ReadyCells, InflammaDry, AdenoPlus, ELVIRA, ELVIS, Thyretain and Savanna. The Company sells its products directly to end-users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers, as well as for individual, non-professional, over-the-counter (OTC) use.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
| SECTOR: | PASS |
| SALES: | PASS |
| CURRENT RATIO: | PASS |
| LONG-TERM DEBT IN RELATION TO NET CURRENT ASSETS: | PASS |
| LONG-TERM EPS GROWTH: | FAIL |
| P/E RATIO: | PASS |
| PRICE/BOOK RATIO: | PASS |
Detailed Analysis of QUIDEL CORPORATION
UFP INDUSTRIES INC (UFPI) is a mid-cap value stock in the Forestry & Wood Products industry. The rating according to our strategy based on Benjamin Graham changed from 71% to 86% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: UFP Industries, Inc. is a holding company with subsidiaries throughout North America, Europe, Asia, and Australia, which supply products primarily manufactured from wood, wood and non-wood composites, and other materials. The Company has three segments: Retail, Industrial and Construction. Retail segment offers a portfolio of outdoor living products, including wood and wood composite decking and related accessories, decorative lawn and garden products, and craft and hobby products. Industrial segment manufacturers and agricultural customers who use pallets, specialty crates, wooden boxes and other containers used for packaging, shipping and material handling purposes, as well as various other products, including protective packaging, used in a variety of different applications. Construction segment is made up of customers in four primary markets, factory-built housing, site-built residential construction, commercial construction and concrete forming.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
| SECTOR: | PASS |
| SALES: | PASS |
| CURRENT RATIO: | PASS |
| LONG-TERM DEBT IN RELATION TO NET CURRENT ASSETS: | PASS |
| LONG-TERM EPS GROWTH: | PASS |
| P/E RATIO: | PASS |
| PRICE/BOOK RATIO: | FAIL |
Detailed Analysis of UFP INDUSTRIES INC
More details on Validea's Benjamin Graham strategy
About Benjamin Graham: The late Benjamin Graham may be the oldest of the gurus we follow, but his impact on the investing world has lasted for decades after his death in 1976. Known as both the "Father of Value Investing" and the founder of the entire field of security analysis, Graham mentored several of history's greatest investors -- including Warren Buffett -- and inspired a slew of others, including John Templeton, Mario Gabelli, and another of Validea's gurus, John Neff. Graham built his fortune and reputation after living through some extremely difficult times, including both the Great Depression and his own family's financial woes following his father's death when Benjamin was a young man. His investment firm posted per annum returns of about 20 percent from 1936 to 1956, far outpacing the 12.2 percent average return for the market during that time.
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
%20Real-Time%20Quotes%20%7C%20Nasdaq&_biz_n=0&rnd=258094&cdn_o=a&_biz_z=1741515931037)
